Liquid Biopsy Foretells Immunotherapy Outcomes: Predicts Res

Using a “liquid biopsy” to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develo

Related Keywords

Joseph Murray , Valsamo Elsa Anagnostou , Johns Hopkins , Lung Cancer Precision Medicine Center , Clinical Cancer Research On Nov , Allegheny Health Network Cancer Institute , Bloomberg Kimmel Institute For Cancer Immunotherapy , Johns Hopkins Kimmel Cancer Center , Allegheny Health Network Cancer Institute In Pittsburgh , Kimmel Institute , Allegheny Health Network Cancer , Clinical Cancer Research , Precision Oncology Analytics , Johns Hopkins Molecular Tumor Board ,